Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immunocore Holdings plc - American Depositary Shares
(NQ:
IMCR
)
39.50
-0.63 (-1.57%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Immunocore Holdings plc - American Depositary Shares
< Previous
1
2
3
4
Next >
Immunocore (IMCR) Q2 2025 Earnings Call Transcript
↗
November 27, 2025
Immunocore (IMCR) Q2 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Growth Picks: 3 Low-Cost Stocks That Could Double in Value
↗
October 27, 2025
Via
MarketBeat
Immunocore (IMCR) Q2 Revenue Jumps 30%
↗
August 07, 2025
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Immunocore Holdings PLC (NASDAQ:IMCR) Beats Q2 2025 Revenue and EPS Estimates with Strong KIMMTRAK Sales Growth
↗
August 07, 2025
Immunocore (IMCR) beat Q2 2025 estimates with $98M revenue (+30% YoY) and a narrower EPS loss. KIMMTRAK sales surged 32%, while pipeline progress and strong cash position ($882.8M) boosted investor...
Via
Chartmill
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Demystifying Immunocore Holdings: Insights From 9 Analyst Reviews
↗
June 02, 2025
Via
Benzinga
What Analysts Are Saying About Immunocore Hldgs Stock
↗
February 27, 2025
Via
Benzinga
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Analyst Expectations For Immunocore Hldgs's Future
↗
January 27, 2025
Via
Benzinga
Analyst Expectations For Immunocore Holdings's Future
↗
April 07, 2025
Via
Benzinga
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday
↗
March 20, 2025
Via
Benzinga
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
↗
December 13, 2024
Morgan Stanley downgrades Amicus Therapeutics, Immunocore, and Immuneering, citing pricing challenges, pipeline updates, and cautious growth outlooks.
Via
Benzinga
3 Fast-Growing Stocks Analysts See Doubling in Price
November 11, 2024
Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.
Via
MarketBeat
Navigating 8 Analyst Ratings For Immunocore Hldgs
↗
November 11, 2024
Via
Benzinga
A Closer Look at 9 Analyst Recommendations For Immunocore Hldgs
↗
October 24, 2024
Via
Benzinga
Analyst Ratings For Immunocore Hldgs
↗
October 07, 2024
Via
Benzinga
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
September 17, 2024
Via
Benzinga
Analyst Expectations For Immunocore Hldgs's Future
↗
September 17, 2024
Via
Benzinga
The Latest Analyst Ratings For Immunocore Hldgs
↗
August 28, 2024
Via
Benzinga
Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
↗
August 09, 2024
Via
Benzinga
3 Small-Cap Stocks with Significant Growth Potential
↗
August 06, 2024
As sector rotation continues, it could be time for investors to consider these small-cap growth stocks that institutions love.
Via
InvestorPlace
Peeling Back The Layers: Exploring Immunocore Hldgs Through Analyst Insights
↗
July 10, 2024
Via
Benzinga
Analyst Expectations For Immunocore Hldgs's Future
↗
May 24, 2024
Via
Benzinga
Where Immunocore Hldgs Stands With Analysts
↗
April 29, 2024
Via
Benzinga
Immunocore Hldgs Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
↗
April 11, 2024
Via
Benzinga
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 03, 2024
Via
Benzinga
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
May 24, 2024
Via
Benzinga
Key Takeaways From Immunocore Hldgs Analyst Ratings
↗
February 29, 2024
Via
Benzinga
IMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024
↗
May 08, 2024
IMCR stock results show that Immunocore Hldgs missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
↗
March 13, 2024
One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.
Via
InvestorPlace
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
